AKOYA BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On January 8, 2023, Akoya Biosciences, Inc. (the "Company") issued a press release announcing its preliminary unaudited financial results for the three months and full-year ended December 31, 2022. A copy of this release is furnished as Exhibit 99.1 hereto.

The information under Item 2.02 of this Current Report on Form 8-K, including the press release furnished as Exhibit 99.1, is being furnished, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings, whether made before or after the date hereof, regardless of any general incorporation language in any such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.   Description of Exhibits

  99.1          Press Release, dated January 8, 2023




                                       2

© Edgar Online, source Glimpses